Adaptive Biotechnologies (ADPT) Surges to First Profit and Lifts Guidance—Has the Investment Case Evolved?
Adaptive Biotechnologies reported third quarter 2025 results, posting sales of US$93.97 million and net income of US$9.55 million,…
Browsing Tag